Cortechs.ai

Cortechs.ai, founded with the mission to enhance clinical insights through quantitative imaging, specializes in developing advanced brain imaging software. Their core products, including NeuroQuant® and NeuroQuant® MS, are designed to assist neurologists and radiologists in diagnosing and monitoring neurological conditions such as Alzheimer's disease and multiple sclerosis. By providing a convenient and cost-effective means to quantify brain structures, Cortechs.ai aims to improve patient outcomes in clinics and research centers globally.

Notable affiliates of Cortechs.ai include leading neurologists and radiologists who utilize their software in clinical practice and research. The company has secured investments from prominent healthcare and technology investors, contributing to its growth and innovation. Key achievements include widespread adoption of their software in hundreds of medical facilities worldwide, significantly impacting the field of neuroimaging by enhancing diagnostic accuracy and efficiency.